Former Trump campaign lawyer Jenna Ellis has pleaded guilty in the Georgia election subversion case, marking a significant development for Fulton County District Attorney Fani Willis. Ellis pleaded guilty to one count of aiding and abetting false statements and has agreed to cooperate with prosecutors and testify against other top figures in future trials. This includes former Trump campaign lawyer Sidney Powell and Kenneth Chesebro, who have also pleaded guilty in the case.
In her plea, Ellis expressed remorse and disavowed her involvement in Trump’s attempts to overturn the 2020 election. She implicated Rudy Giuliani, accusing him of peddling false voter-fraud theories and admitting to aiding Giuliani and another Trump lawyer in making false statements to members of the Georgia Senate.
As part of the agreement, prosecutors dropped some of Ellis’ charges in exchange for her cooperation. However, she is prohibited from posting on social media about the case while the proceedings are ongoing. It is worth noting that Ellis has faced unrelated disciplinary proceedings in Colorado, where she admitted that many of her post-election public statements were false.
The guilty pleas from Ellis, Powell, and Chesebro provide a boost to District Attorney Fani Willis, who is preparing for trials against Trump, Giuliani, Mark Meadows, and other top figures. These trials will likely be high-profile and closely watched as they delve into the actions taken by the Trump campaign following the 2020 election.
Despite her legal troubles, Ellis has publicly supported Florida Gov. Ron DeSantis in the 2024 Republican presidential primary. She has even managed to raise over $216,000 through an online crowdfunding website, showcasing her continued support within certain corners of the Republican base.
Overall, the guilty pleas in the Georgia election subversion case have brought significant attention to the ongoing investigations and trials related to the 2020 election. With Ellis, Powell, and Chesebro cooperating with prosecutors, it remains to be seen how their testimonies will shape the outcome of these high-profile trials.